why choose us

First received: February 24, 2023

Clinical Trial: Study of Effect of Azeliragon in Patients Refractory to First-Line Metastatic Pancreatic Cancer

Study Status: Completed

Recruit Status: RECRUITING

Condition: Metastatic Pancreatic Cancer

Study Type: INTERVENTIONAL


Official Title: A Phase I/II Open Label Study to Assess Safety and Preliminary Evidence of a Therapeutic Effect of Azeliragon in Patients Refractory to First-Line Treatment of Metastatic Pancreatic Cancer

Brief Summary: This is an open label study to determine the safety and preliminary evidence of a therapeutic effect of azeliragon in patients refractory to first-line or second-line treatment of metastatic pancreatic cancer.

Read more